Clinical trial
Early Identification and Prognosis Prediction of Sepsis Through Multiomics
NCT05305469 is registered in ClinicalTrials.gov with Yantai Yuhuangding Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Identification and Prognosis Prediction of Sepsis Through Multiomics
- Lead sponsor
- Yantai Yuhuangding Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- December 31, 2025
- Enrollment
- 900 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.